I could be wrong but the reference to the NDIS is probably a pricing issue which would be negotiated once all approvals are in place.
I recall a migraine drug which cost the Govt $10K a pop because the company (Glaxo?} presented a cost/benefit analysis to justify the price. So NDIS savings and GDP/PAYE benefits would probably need to be factored in.
I could be wrong but the reference to the NDIS is probably a...
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.1¢ |
Change
-0.003(4.69%) |
Mkt cap ! $62.06M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.4¢ | 6.0¢ | $35.24K | 571.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 113554 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 200000 | 1 |
View Market Depth
| Last trade - 14.57pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.1¢ |
Change
-0.003 ( 3.17 %) |
||||
| Open | High | Low | Volume | ||
| 6.4¢ | 6.4¢ | 6.1¢ | 236904 | ||
| Last updated 14.57pm 14/06/2024 ? | |||||
| NTI (ASX) Chart |